Human Umbilical Cord Mesenchymal Stem Cells for Severe Neurological Sequelae due to Anti-<i>N</i>-Methyl-d-Aspartate Receptor Encephalitis: First Case Report.

Publication Year: 2022

DOI:
10.1177/09636897221110876

PMCID:
PMC9277426

PMID:
35815930

Journal Information

Full Title: Cell Transplant

Abbreviation: Cell Transplant

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Transplantation

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: L.N.T., V.T.H., H.L.T., P.A.T.N., D.M.H., and D.V.N. are employed by the not-for-profit Vinmec Healthcare System. M.H. declared an advisory role for Regenerative Medicine at Vinmec Healthcare System."

Evidence found in paper:

"Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The patient was not required to pay for any part of the cell therapy, including fees for umbilical cord collection, cell culture, cell processing, cell infusions, related medications, and single room stay and care during the treatment. The payment was kindly covered by the Kind Heart Foundation ( http://quythientam.com )."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025